vTv Therapeutics Inc. Cash Flow Statement
VTVT|11 years of annual SEC 10-K data (FY2015-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 11 fiscal years. All figures from audited SEC 10-K filings.
vTv Therapeutics Inc. used $19M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$20.3M | -$19.2M | -$13.0M | -$8.5M | -$13.0M | -$7.9M | -$16.1M | -$16.4M | -$27.5M | -$36.1M | -$48.2M |
| Depreciation & Amortization | $90.0K | $92.0K | $89.0K | $94.0K | $39.0K | $218.0K | $197.0K | $265.0K | $501.0K | $864.0K | $1.1M |
| Operating Cash Flow | -$19.1M | -$16.0M | -$19.3M | -$18.0M | -$23.0M | -$26.9M | -$44.6M | -$48.2M | -$36.9M | -$30.8M | -$41.7M |
| Capital Expenditures | - | $21.0K | $0 | $0 | $70.0K | $5.0K | $57.0K | $87.0K | $104.0K | $33.0K | $181.0K |
| Free Cash Flow | - | -$16.0M | -$19.3M | -$18.0M | -$23.1M | -$26.9M | -$44.6M | -$48.3M | -$37.0M | -$30.8M | -$41.9M |
| FCF Margin | - | -795.0% | -482.1% | -280.6% | -835.3% | -216.0% | -15332.3% | -7617.7% | -7138.7% | -1989.2% | -4289.4% |